Since 2002, when the primary outcome paper for the Ocular Hypertension Treatment Study (OHTS) was first published in the Archives of Ophthalmology, the ophthalmic community has been bombarded by a flurry of presentations highlighting the benefits of topical medical therapy for ocular hypertensive individuals and the importance of careful risk assessment when determining who should be treated. Although the focus has been appropriately concentrated on these issues, there is still a wealth of information generated by OHTS that warrants highlighting. Thus, the purpose of this brief overview is to highlight the key papers published to date, associated with this trial and offer take-home messages that are relevant to clinical practice.
展开▼